51 Eastcheap,
London,
EC3M 1JP

+44 1157 840 500.

The immune system produces autoantibodies targeting cancer cells. Oncimmune’s technology profiles the autoantibodies raised against cancer cells to assist with the early diagnosis of cancer and to characterise cancer to help predict response to treatment

Antibodies Stabilisation, Antigens, Diagnostic Tests - Autoimmune Diseases, Early CDT (liver cancer), Early CDT (lung cancer), In Vitro Diagnostic Devices, In Vitro Diagnostic Kits